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AbstrACt
Objectives To identify baseline patient characteristics that are 
(1) associated with a poor outcome on follow-up regardless 
of which treatment was provided (prognosis) or (2) associated 
with a successful outcome to a specific treatment (treatment 
effect modifiers).
Design Systematic literature review according to Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis 
guidelines.
Data sources Medline, Embase, Cinahl, Web of Science, 
Cochrane, SportDiscus, OT Seeker and PsychInfo were 
searched for prospective cohort studies up to February 2019 
without limitation in publication date.
Eligibility criteria Prospective cohort studies reporting either 
prognostic factors or treatment effect modifiers on persistent 
musculoskeletal pain in 0-year-old to 19-year-old children and 
adolescents. Pain caused by tumours, fractures, infections, 
systemic and neurological conditions were excluded.
Outcome measures Our primary outcome was 
musculoskeletal pain at follow-up and identification of any 
baseline characteristics that were associated with this outcome 
(prognostic factors). No secondary outcomes were declared.
Method Two reviewers independently screened abstracts 
and titles. We included prospective cohort studies investigating 
the prognosis or treatment effect modifiers of 0-year-old 
to 19-year-old children and adolescents with self-reported 
musculoskeletal pain. Risk of bias assessment was conducted 
with the Quality in Prognostic Studies tool.
results Twenty-six studies yielding a total of 111 unique 
prognostic factors were included. Female sex and psychological 
symptoms were the most frequent investigated prognostic 
factors. Increasing age, generalised pain, longer pain duration 
and smoking were other identified prognostic factors. No 
treatment effect modifiers were identified.
Conclusion Several prognostic factors are associated 
with a poor prognosis in children and adolescents with 
musculoskeletal pain. These prognostic factors may help 
guide clinical practice and shared decision-making. None of 
the included studies was conducted within a general practice 
setting which highlights an area in need of research.
PrOsPErO registration number CRD42016041378.
IntrODuCtIOn
General practice is often the point of first 
contact into the healthcare system and 
musculoskeletal pain complaints are the 
most common cause of contact. The case 
workload due to musculoskeletal pain 
complaints in children and adolescents is 
estimated to be 4%–8% of the UK general 
practice1 and musculoskeletal pain is 
known to affect half of all children and 
adolescents, increasing exponentially in 
frequency around the age of 10 years.2–6 A 
recent systematic review reported that 40% 
of an adolescent population had experi-
enced pain during the last 6 months.3 The 
most common pain sites are the knee and 
back.7 Musculoskeletal pain has a detri-
mental impact on the adolescents’ quality 
of life and may cause them to withdraw 
from school, social and athletic activities.8 9 
Musculoskeletal pain in children and 
adolescents has previously been consid-
ered a self-limiting condition without 
long-term impact.10 Recent cohort studies 
show that 16%–32% of patients with knee 
pain still report knee pain 1 year later10 11 
and that 21% of 12-year to 35-year olds had 
persistent knee pain 6 years after initial 
contact to their general practitioner.10 
Collectively, these studies highlight that a 
significant proportion of adolescents will 
report pain even years later. Who are the 
strengths and limitations of this study
 ► This review is highly updated with a search up to 
February 2019.
 ► No previous review has aimed to identify prognostic 
factors in children and adolescents with musculo-
skeletal pain with the purpose of informing clinical 
practice.
 ► In collaboration with a research librarian, a highly 
sensitive search for each of the eight databases was 
developed to ensure an inclusion of the totality of 
previous research.
 ► Two reviewers independently carried out the screen-
ing and data extraction was executed in the same 
manner for all included studies.
 ► No meta-analysis was conducted due to a hetero-
geneity of patient population, setting and endpoints.
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children and adolescents with a particularly high risk 
of long-lasting musculoskeletal pain? This is one of 
the most common questions from our stakeholder 
interviews with general practitioners (unpublished 
stakeholder event).
Knowledge of prognostic factors can inform the 
general practitioner of the prognosis of their patients 
and enable them to identify those with a poor prognosis 
to stratify care, address modifiable risk factors and better 
understand chronic pain conditions. The latest systematic 
review on prognostic factors for adolescents with muscu-
loskeletal pain12 ended their literature search in July 2015 
which makes for a timely update. So far, no systematic 
reviews have aimed to inform clinical practice of prog-
nostic factors in children, and adolescents with muscu-
loskeletal pain. Therefore, we aimed to identify baseline 
patient characteristics associated with a (1) poor outcome 
on follow-up (prognosis) or (2) successful outcome of a 
treatment (treatment effect modifiers).
MEthODs
Literature search
We searched in Medline, Embase, Cinahl, Web of Science, 
Cochrane, SportDiscus, OT Seeker and PsychInfo from 
their inception until February 2019 without limitation on 
date. An experienced research librarian collaborated in 
the production of individual search strategies for each of 
the eight databases (see online supplementary appendix 
1).
Eligibility criteria
Study population and design
We included prospective studies that investigated prog-
nostic factors or treatment effect modifiers in children 
and adolescents 0-year to 19-year olds, with any type and 
location of musculoskeletal pain. Musculoskeletal pain 
was defined as pain in muscle, tendon, bone and joint.13 
We included musculoskeletal pain types, reported in 
each of our included studies, without further definition 
of or changes in the designations chosen by the respective 
authors. We excluded pain knowingly caused by tumours, 
fractures, infections, systemic and neurological condi-
tions, and stomach pain, because of insufficient differ-
entiation between musculoskeletal stomach pain and 
stomach pain by other causes. Furthermore, we included 
all prospective studies, independent of intervention and 
randomised trials including all types of comparators. As 
expected, most studies did not use a comparator because 
they were prospective cohort studies. Similar to interven-
tion, these studies were included independent of compar-
ators. There were no restrictions on the type of setting or 
language.
Review process
Two reviewers (NP and AR) independently screened titles 
and abstracts for studies addressing the question: What 
are the prognostic factors and treatment effect modifiers 
for children and adolescents with musculoskeletal pain? 
Full-text articles were then screened, adding primary 
reasons for exclusion.
There was no blinding of the review authors to the 
journal titles, authors or institutions. Reference lists of all 
included studies were screened for eligible publications 
that may have been missed during the initial search. The 
study selection process was finalised without any disagree-
ments on included studies. EndNote was used to remove 
duplicates and NP manually checked for duplicates 
afterwards.
Data extraction
Data for the included studies were extracted by NP in the 
form of: study characteristics (study design, recruitment 
setting and duration of follow-up), participant characteris-
tics (musculoskeletal pain type, baseline age, study popu-
lation and persistent pain at follow-up in females, males 
and combined) (table 1) and prognostic factors with their 
reported estimates: ORs, relative risks (RR), 95% CI) 
and/or p values. If possible, we extracted the adjusted 
associations.
Data were extracted with a predefined data extraction 
form inspired by The Cochrane Collaboration.14
Outcomes and endpoints
Our primary outcome of interest was musculoskeletal pain 
at follow-up. We wanted to identify any baseline character-
istics that were associated with this outcome (prognostic 
factors). We used the term ‘pain persistence’ to describe 
participants who had pain at both baseline and follow-up, 
without applying restrictions on either pain measurement 
or on follow-up time points.
Risk of bias
Risk of bias was assessed using the Quality in Prognostic 
Studies (QUIPS) tool.15 On the study level, NP and AR 
independently rated the 26 included studies and reached 
consensus on all risk of bias assessments (table 2). Prog-
nostic factors from studies with a high risk of bias, were 
excluded from figure 1.
Involvement of general practitioners
With stakeholder involvement and input from a panel of 
general practice researchers experienced in musculoskel-
etal research, we subgrouped our identified prognostic 
factors in accordance with the biopsychosocial model16 17:
Biological prognostic factors
 ► Female sex.
 ► Older age.
 ► Body measurement factors.
 ► Physical functioning.
 ► Pain characteristics.
Psychological prognostic factors
 ► General psychological factors.
 ► Depressive factors.
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Social prognostic factors
 ► General social factors.
 ► Factors related to sleep/daytime tiredness.
 ► Physical activity/inactivity.
 ► Alcohol.
 ► Smoking.
Reporting of results
We were not able to conduct our a priori planned 
meta-analysis because of heterogeneity in terms of patient 
population, setting and time points for follow-up. The 
evidence on included prognostic factors was reported 
with ORs, RR and/or p values. As OR and RR may differ 
in interpretation, we reported them separately. A statisti-
cally significant association between a patient character-
istic and an outcome was defined as an RR or OR above 
or below 1 that did not include 1 in the 95% CI. As for 
p value, a statistically significant association was defined 
as p<0.05. Average on pain at follow-up was calculated as 
average of individual studies reporting same musculoskel-
etal pain type at same follow-up duration (figure 2).
We used the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses checklist when writing our 
report18 (see online supplementary appendix 2).
Patient and public involvement
No patients or public were involved in the present study.
rEsuLts
Included studies
Figure 3 reports the results of the search strategy. Of the 
48 538 titles identified, 41 735 studies were screened, and 
26 studies9 11 17 19–41 were included. All included studies 
were prospective studies. The included studies used a mix 
of different measures to capture pain at follow-up. Muscu-
loskeletal pain types included in our search were general 
musculoskeletal pain, neck, back, lower back, lower limb, 
knee and growing pain. No treatment effect modifiers 
were identified.
Extracted data from the included studies: MSK pain 
type, baseline age, recruitment setting, size of study popu-
lation, follow-up and percentage of study participants 
who represented persistent pain at follow-up, both strati-
fied by gender and combined.
risk of bias
The most common reasons for a moderate or high risk 
of bias were inadequately described study participation 
and statistical analyses (n=6, 23%), attrition rates (n=5, 
20%) and poor adjustment for confounders (n=11, 42%). 
Three studies were rated with high risk of bias. With the 
purpose of filtering the results of prognostic factors, we 
excluded these studies from the final results depicted in 
figure 1.
Risk of bias in included studies. With the QUIPS tool 
studies were assessed on the overall risk of bias within 
each of the six domains and rated as low, moderate or S
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high risk of bias. Three studies were rated with high risk 
of bias, and hence excluded from the final results.
Prognosis
Figure 2 highlights the persistence of musculoskeletal 
pain in all included studies at different follow-up time 
points and is calculated based on persistent pain at 
follow-up in table 1. At 1 year follow-up, an average of 
54.4% with general musculoskeletal pain, an average of 
41.8% with neck pain and 48.8% with knee pain reported 
pain. At 4-year follow-up, 63.5% with general musculo-
skeletal pain, 33.5% with neck pain and 26% with low 
back pain reported pain. At 9-year follow-up, 59% with 
general musculoskeletal pain reported pain. A complete 
report of all the identified prognostic factors is listed 
in online supplementary table 1. Figure 1 depicts the 
majority of these prognostic factors, stratified by pain 
type, sex, study population size and follow-up (please see 
online supplemental table 1 for explanatory notes).
Figure 1 Prognostic factors for persistent musculoskeletal pain, according to pain type, population size, sex, follow-up and 
the biopsychosocial model.
Figure 2 Persistent musculoskeletal pain, stratified in pain type and follow-up. The included studies investigated pain at 
follow-up time points ranging from 3 months to 11 years. General musculoskeletal pain (black) persisted in >50% of participants 
after 1, 2, 3, 4 and 9 years of follow-up.
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Very few prognostic factors were reported on back 
pain, growing pain, lower limb pain and widespread 
musculoskeletal pain (see online supplementary table 1); 
consequently, they were excluded from figure 1. Table 3 
condenses the results from online supplementary table 1 
and highlights four prognostic factors on four different 
musculoskeletal pain types. Below each factor are sugges-
tive questions to provide the general practitioner with 
insight into the patient’s prognosis. Table 3 and figure 1 
can be printed and used by a general practitioner at time 
of initial consultation with a 0-year-old to 19 year-old 
patient with musculoskeletal pain.
Please see the online supplementary file-video for an 
animation showing how our findings can be used in a 
clinical setting.
Prognostic factors associated with pain at follow-up
A total of 111 prognostic factors were associated with 
musculoskeletal pain at follow-up, of which most were on 
general musculoskeletal pain and low back pain (table 3). 
Online supplementary table 1 includes these results and 
further detailed depiction of prognostic factors.
Female sex was the most frequently identified prog-
nostic factor associated with musculoskeletal pain at 
follow-up. Eleven studies identified psychological factors 
(eg, depression, anxiety and low self-esteem) to be associ-
ated with pain at follow-up in seven out of nine musculo-
skeletal pain types.9 17 19 21 22 25 26 30 35 36 40
Longer pain duration was associated with pain at 
follow-up across four musculoskeletal pain types: muscu-
loskeletal, low back, knee and back pain.21 23 25 36
Figure 3 PRISMA flowchart presenting the flow of citations reviewed in the course of the systematic review. Forty-eight 
thousand five hundred and thirty-eight articles were identified through search in eight databases, resulting in 223 articles for full-
text eligibility screen and a final number of 26 studies for inclusion yielding 111 prognostic factors on musculoskeletal pain. 
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Five studies identified sleep-related problems associ-
ated with outcome.22 26 30 35 40
Other indicators for musculoskeletal pain at follow-up 
were increasing age,9 22 27 30 smoking,32 35 parental 
pain17 23 41 and multisite pain.22 23 40
Figure 1 summarises all identified prognostic factors 
for musculoskeletal pain at follow-up, stratified by pain 
type, study population size, sex and follow-up.
non-significant prognostic factors
We identified a total of 134 patient characteristics across 
nine musculoskeletal pain types and different follow-up 
time points with a non-significant association with muscu-
loskeletal pain at follow-up (see online supplementary 
table 1).
Increasing age11 21 23 28 29 31 36 41 was the most frequently 
identified baseline factor with a non-significant associa-
tion to musculoskeletal pain at follow-up. Multiple studies 
reported non-significant evidence on higher body mass 
index23 26 28 and hypermobility.11 30 40
DIsCussIOn
Principal findings
Female sex was consistently associated with an increased 
risk (OR and RR between 1.24 and 3.66) of pain at 
follow-up across six different musculoskeletal pain types. 
Depressive symptoms,9 17 19 22 24 26 30 35 36 40 factors related 
to sleep/daytime tiredness22 26 30 35 40 and parental pain 
condition17 23 41 were all associated with a higher risk 
of pain at follow-up. Collectively, the identified studies 
included prognostic factors across all aspects of the 
biopsychosocial model, despite a main focus on biological 
factors. Increasing age was identified as both a significant 
and a non-significant prognostic factor in the included 
studies. This conflicting finding reflects the uncertainty 
surrounding the importance of age as a prognostic factor. 
A complete overview of strength of associations can be 
found in online supplementary table 1.
strengths and limitations in comparison with existing 
literature
The latest systematic review on prognostic factors for 
children and adolescents with musculoskeletal pain 
ended their search in July 2015 which makes for a timely 
update.12 In addition to adding newer studies, our review 
differs from the previous with search in more databases, 
no restriction on publication language and no restriction 
on pain duration.41 Furthermore, this review is highly 
updated with a search up to February 2019 and the 
protocol for this review was developed using the Preferred 
Reporting Items for Systematic Review and Meta-Anal-
ysis Protocols 2015 statement (see online supplementary 
appendix 3). Despite methodology differences, we did 
not identify additional studies from inception to 2015, but 
identified three new studies from January 2016 to 2017. 
These studies added important knowledge of female 
sex, pain frequency and the prognosis of knee pain and 
general musculoskeletal pain. Thereby, supporting the 
previous research. Despite the commonality of children 
and adolescents with musculoskeletal pain in general 
practice,6 we did not identify a single study with a popu-
lation of children or adolescents recruited from general 
practice.
A previous review on prognostic factors for adults 
with musculoskeletal pain in primary care was published 
in 201742 with findings similar to ours, that is, female 
gender, older age, depression/anxiety and long pain 
duration were found associated with an increased risk of 
Table 3 What to ask in clinical practice? Four prognostic factors belonging to four frequent musculoskeletal pain types in 
general practice: General musculoskeletal pain, low back pain, neck pain and knee pain. The questions are proposals towards 
assessment of prognosis on musculoskeletal pain
General musculoskeletal 
pain Low back pain Neck pain Knee pain
Prognostic 
factors
 ► Female sex and female 
smokers.
 ► Day tiredness/fatigue.
 ► Physical activity versus 
none.
 ► Depressive symptoms.
 ► Higher lumbar 
mobility.*
 ► Longer pain duration.
 ► Peer problems.
 ► Smoking.
 ► Female sex.
 ► Depressive symptoms.
 ► Multisite pain versus 
localised.
 ► Day tiredness.
 ► Increasing age.
 ► Daily pain.
 ► Sport >2 t/week.
 ► Low quality of life.
Questions  ► Do you smoke?(F).
 ► Do you feel tired during the 
day?
 ► Do you do sport?
 ► Are you feeling mentally 
well?
 ► Clinical examination.
 ► How long have you 
had pain?
 ► Do you have friends/
do you experience 
bullying?
 ► Do you smoke?
 ► Are you feeling mentally 
well?
 ► Do you have pain in more 
than one musculoskeletal 
region?
 ► Do you feel tired during 
the day?
 ► Do you experience 
daily pain.
 ► Do you do practice 
sport frequently?
 ► How are things 
at school and at 
home?†
*To be evaluated by clinical examination.
†This question is a suggestion for use in evaluation of quality of life.
F, female patients.
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musculoskeletal pain at follow-up. This suggest that some 
of the prognostic factors function well across the age 
range and their use is not isolated to specific age groups.
Explanation of findings and implications for clinical practice
Our findings suggest that females are at higher risk of 
persistent pain. Previous research highlights potential 
sex differences in pain responses by assessing pain inten-
sity and threshold and conclude that females display 
greater sensitivity to multiple pain modalities compared 
with males.43 Importantly, pain-coping strategies have 
been found to differ between the sexes.44 45 Females 
make use of social support, cognitive reinterpretation 
and positive self-statements, while males use behavioural 
distraction and problem-focused tactics to manage pain. 
This could partly explain the sex-difference in prognosis 
and may open new opportunities for targeted treatment 
to improve long-term outcomes of young females with 
musculoskeletal pain.
The current results point towards both modifiable 
(psychological factors, smoking and peer problems) and 
non-modifiable (sex, age and pain duration) factors asso-
ciated with prognosis. Despite time constraints in general 
practice, most of these factors can be extracted from elec-
tronic stored patient data, psychometric tests and exam-
ination in a clinical general practice setting.
By asking your patient a few questions at the first consul-
tation of musculoskeletal pain, the general practitioner 
may improve their understanding of their patients’ risk of 
pain in the future. In the case of a present, baseline factor 
with a poor prognosis, for example, smoking among low 
back pain patients, the general practitioner now both has 
a scientific reason for and the clinical tool to modulate 
this factor. By prescribing cessation of smoking, thus, 
making an effort to improve the outcome for this patient.
Treatment of musculoskeletal pain requires the general 
practitioner to apply a multifactorial rather than a single-
factor approach, hence, including the entire person 
and their life circumstances when treating patients with 
pain.16 46 47 Clinicians must be aware of the multifacto-
rial aetiology and consider biological, psychological and 
social factors of musculoskeletal pain when addressing 
patient’s coping behaviour and cognitive appraisal.48
Implications for future research
Most of our included studies investigated biological prog-
nostic factors (54 factors). Fewer investigated social (35 
factors) and even fewer psychological prognostic factors 
(22 factors). Future research should include the entire 
patient, in terms of biological, psychological and social-re-
lated components and aim to study these prognostic 
factors in a general practice setting. There is a dearth of 
knowledge of how psychosocial factors are associated with 
prognosis and how general practitioners can harness this 
information to tailor treatment and information to their 
patients. Despite the potential importance of pain, ‘who’ 
the patient is should not be discounted. Geographical 
location of home, parental pain, profession and income, 
and social identity in terms of cultural differences, reli-
gious beliefs and relations could be important because 
we know from the biopsychosocial model that social back-
ground is important in relation to pain coping.
Only one study did follow-up after 4, 6.5, 9 and 11 years, 
respectively, which highlights the lack of long-term cohort 
studies on prognosis and impact of musculoskeletal pain 
in youth.
Almost one in every two children and adolescents still 
reported pain even years later.10 11 49 This highlights the 
importance of prognosis of pain in children and adoles-
cents. Healthcare practitioners should be cognisant not 
to assume that musculoskeletal pain during childhood or 
adolescence is transient or self-limiting.
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